6/22/2020 | SP | New Issue: UBS sells $590,000 airbag return optimization notes on biotech ETF
|
7/29/2019 | SP | New Issue: RBC sells $400,000 issuer callable contingent coupon barrier notes on ETF, stocks
|
3/4/2019 | SP | New Issue: Barclays sells $560,000 buffered SuperTrack notes on Nasdaq biotech fund
|
12/18/2018 | SP | RBC to price PLUS linked to basket of two indexes and six funds
|
4/2/2018 | SP | New Issue: Citigroup sells $1.25 million autocallable contingent coupon notes on biotech ETF
|
2/28/2018 | SP | New Issue: Credit Suisse sells $6 million contingent coupon autocallables tied to three ETFs
|
1/23/2018 | SP | New Issue: Credit Suisse prices $1.05 million buffered accelerated return notes on funds
|
12/19/2017 | SP | New Issue: UBS sells $3.3 million trigger autocallable contingent yield notes on biotech ETF
|
11/17/2017 | SP | New Issue: Deutsche Bank sells $845,000 capped knock-out notes on biotech ETF
|
11/17/2017 | SP | New Issue: JPMorgan prices $1.16 million 15% contingent interest autocallables tied to two funds
|
11/9/2017 | SP | JPMorgan plans contingent interest autocallables on biotech, LatAm ETFs
|
11/9/2017 | SP | Deutsche Bank to price capped knock-out notes linked to biotech ETF
|
9/27/2017 | SP | Deutsche Bank plans capped return enhanced notes linked to biotech ETF
|
9/11/2017 | SP | New Issue: BMO sells $382,000 bullish enhanced notes on iShares Biotechnology ETF
|
8/24/2017 | SP | BMO plans bullish notes due 2018 on iShares Nasdaq Biotechnology ETF
|
8/23/2017 | SP | New Issue: Credit Suisse sells $1.31 million contingent coupon callable yield notes on biotech ETF, Russell
|
8/15/2017 | SP | Credit Suisse plans contingent coupon callable yield notes on Russell, Biotech ETF
|
6/19/2017 | SP | New Issue: Credit Suisse prices $1.6 million Bares linked to iShares biotech ETF
|
6/13/2017 | SP | New Issue: Barclays prices $521,000 SuperTrack notes tied to iShares Nasdaq Biotechnology
|
6/12/2017 | SP | Credit Suisse plans Bares linked to iShares Nasdaq Biotechnology ETF
|
5/26/2017 | SP | New Issue: BMO prices $12,000 6.6% cash-settled autocallables tied to biotech ETF
|
5/26/2017 | SP | Market Commentary: Barclays’ SuperTrack notes tied to iShares Nasdaq Biotech ETF target mildly bullish investors
|
5/23/2017 | SP | Barclays plans SuperTrack notes linked to iShares Nasdaq Biotech ETF
|
5/17/2017 | SP | BMO plans 6.6% cash-settled autocallables tied to Nasdaq biotech fund
|
5/3/2017 | SP | New Issue: BMO prices $97,000 5.7% cash-settled autocallables tied to biotech fund
|
5/3/2017 | SP | New Issue: BMO prices $26,000 7.5% cash-settled autocallables tied to biotech fund
|
4/20/2017 | SP | New Issue: Barclays sells $1.28 million phoenix autocallables tied to biotech fund
|
4/17/2017 | SP | New Issue: BMO sells $32,000 7.2% autocallable cash-settled notes on Nasdaq Biotech
|
4/10/2017 | SP | New Issue: Barclays sells $1 million phoenix autocallables on Stoxx, biotech ETF
|
4/10/2017 | SP | New Issue: BMO sells $14,000 5.4% autocallable cash-settled notes on Nasdaq Biotech
|
3/24/2017 | SP | Barclays plans phoenix autocallables on Stoxx, iShares Nasdaq Biotech
|
3/23/2017 | SP | BMO plans 5.4% cash-settled autocallables tied to Nasdaq Biotech fund
|
3/22/2017 | SP | BMO plans 7.2% cash-settled autocallables tied to Nasdaq Biotech fund
|
3/20/2017 | SP | New Issue: Barclays prices $16.08 million of phoenix autocallable notes on three funds
|
3/6/2017 | SP | New Issue: Barclays prices $5.51 million phoenix autocallables due 2019 linked to three funds
|
3/3/2017 | SP | New Issue: BMO prices $15,000 6.6% autocallable cash-settled notes on biotech ETF
|
3/3/2017 | SP | New Issue: BMO prices $50,000 8.4% autocallable cash-settled notes on biotech ETF
|
2/24/2017 | SP | Barclays eyes phoenix autocallables due 2019 linked to three funds
|
2/13/2017 | SP | New Issue: HSBC prices $1 million autocallables linked to biotechnology basket
|
2/9/2017 | SP | New Issue: HSBC prices $1 million autocallable notes linked to basket of biotech ETF, stocks
|
2/9/2017 | SP | New Issue: BMO sells $133,000 8.4% cash-settled autocallables on iShares Nasdaq Biotech
|
2/8/2017 | SP | New Issue: BMO sells $10,000 6.6% cash-settled autocallables on iShares Nasdaq Biotech
|
2/7/2017 | SP | HSBC plans autocallable notes linked to basket of biotech ETF, stocks
|
2/6/2017 | SP | New Issue: Barclays prices $4.94 million phoenix autocallables tied to three funds
|
2/3/2017 | SP | BMO plans 8.4% cash-settled autocallables on iShares Nasdaq Biotech
|
2/3/2017 | SP | BMO plans 6.6% cash-settled autocallables on iShares Nasdaq Biotech
|
1/26/2017 | SP | New Issue: Credit Suisse prices $1.05 million ARES on iShares Nasdaq biotech ETF
|
1/11/2017 | SP | Credit Suisse plans Accelerated Return Equity Securities on biotech fund
|
1/11/2017 | SP | New Issue: Credit Suisse sells $1.53 million high/low coupon autocallables on two funds
|
1/6/2017 | SP | New Issue: JPMorgan prices $3.13 million capped airbag absolute return gears on biotech fund
|
1/5/2017 | SP | BMO plans 6.6% cash-settled autocallables on iShares Nasdaq Biotech
|
1/3/2017 | SP | New Issue: Morgan Stanley prices $4.46 million contingent income autocallables linked to ETFs
|
12/30/2016 | SP | New Issue: RBC sells $2.3 million contingent coupon barrier autocallable on biotech ETF
|
12/14/2016 | SP | BMO plans 6.6% autocallable cash-settled notes linked to biotech ETF
|
12/14/2016 | SP | Barclays plans two-year phoenix autocallables linked to three funds
|
12/13/2016 | SP | New Issue: Citigroup prices $1.29 million barrier notes linked to biotech ETF
|
12/9/2016 | SP | New Issue: BMO prices $12,000 7.2% cash-settled autocallables tied to biotech fund
|
12/9/2016 | SP | New Issue: BMO prices $272,000 9% cash-settled autocallables tied to biotech fund
|
12/6/2016 | SP | New Issue: HSBC prices $3.85 million trigger jump securities linked to biotech ETF
|
12/2/2016 | SP | Citigroup plans barrier notes linked to iShares Nasdaq Biotechnology
|
11/22/2016 | SP | New Issue: Barclays prices $3.17 million phoenix autocallables tied to three funds
|
11/16/2016 | SP | New Issue: Morgan Stanley prices $1.34 million contingent income autocallables linked to biotech ETF
|
11/15/2016 | SP | Barclays plans to price phoenix autocallables linked to three funds
|
11/15/2016 | SP | HSBC plans trigger jump notes tied to iShares Nasdaq Biotechnology
|
11/9/2016 | SP | Morgan Stanley plans contingent income autocallables tied to iShares Nasdaq Biotech
|
11/3/2016 | SP | New Issue: Bank of Montreal prices $40,000 autocallables on iShares Nasdaq Biotech
|
11/2/2016 | SP | New Issue: Bank of Montreal prices $19,000 6% cash-settled autocallables on biotechnology fund
|
10/26/2016 | SP | BMO plans 7.2% autocallable cash-settled notes on iShares Biotech
|
10/25/2016 | SP | BMO plans 9% autocallable cash-settled notes on Nasdaq Biotech ETF
|
10/25/2016 | SP | New Issue: Barclays prices $3.08 million phoenix autocallables tied to three funds
|
10/19/2016 | SP | Barclays plans to price phoenix autocallables linked to three funds
|
10/5/2016 | SP | New Issue: BMO prices $25,000 7.2% autocallable cash-settled notes on biotech fund
|
9/28/2016 | SP | BMO plans 7.8% autocallable cash-settled notes on biotech ETF
|
9/28/2016 | SP | BMO plans 6% autocallable cash-settled notes on biotech fund
|
9/21/2016 | SP | New Issue: JPMorgan prices $9.65 million contingent coupon autocallables tied to three ETFs
|
9/15/2016 | SP | JPMorgan plans contingent coupon autocallables tied to three ETFs
|
9/1/2016 | SP | New Issue: BMO prices $700,000 6.9% autocallable cash-settled notes on biotech ETF
|
9/1/2016 | SP | New Issue: BMO prices $20,000 7.2% autocallable cash-settled notes on biotech ETF
|
8/29/2016 | SP | Bank of Montreal plans 7.2% autocallables on iShares Nasdaq Biotech
|
8/18/2016 | SP | BMO plans 7.2% autocallable cash-settled notes tied to biotech ETF
|
8/16/2016 | SP | New Issue: Barclays prices $8.65 million phoenix autocallables linked to biotech ETF
|
8/5/2016 | SP | Barclays plans phoenix autocallables tied to iShares Nasdaq Biotech
|
8/2/2016 | SP | New Issue: BMO prices $172,000 autocallable cash-settled notes on biotech ETF
|
7/19/2016 | SP | New Issue: RBC prices $2.03 million contingent coupon barrier autocallables tied to three funds
|
7/14/2016 | SP | RBC plans contingent coupon barrier autocallables tied to three funds
|
7/7/2016 | SP | BMO plans 8.1% autocallable cash-settled notes on Nasdaq biotech fund
|
7/5/2016 | SP | New Issue: BMO prices $58,000 8.1% cash-settled autocallables on biotech ETF
|
7/1/2016 | SP | New Issue: Bank of Montreal sells $50,000 6.3% cash-settled autocallables on biotech ETF
|
6/17/2016 | SP | New Issue: RBC prices $3.85 million trigger phoenix autocallables linked to funds
|
6/9/2016 | SP | BMO plans 8.1% autocallable cash-settled notes linked to biotech ETF
|
6/9/2016 | SP | Bank of Montreal plans 6.3% autocallable cash-settled notes linked to biotech ETF
|
6/9/2016 | SP | New Issue: Credit Suisse prices $1 million contingent coupon autocallables on biotech ETF
|
6/7/2016 | SP | New Issue: Bank of Montreal prices $212,000 8.4% cash-settled autocallables on biotech ETF
|
6/7/2016 | SP | New Issue: Bank of Montreal sells $4,000 6.6% cash-settled autocallables on biotech ETF
|
6/3/2016 | SP | New Issue: Barclays prices $4.41 million phoenix autocallables tied to three funds
|
5/25/2016 | SP | Barclays plans phoenix autocallable notes linked to three ETFs
|
5/19/2016 | SP | Credit Suisse plans contingent coupon autocallables on biotech fund
|
5/10/2016 | SP | Bank of Montreal plans 8.4% autocallable cash-settled notes on biotech ETF
|
5/10/2016 | SP | Bank of Montreal plans 6.6% autocallable cash-settled notes on biotech ETF
|
4/29/2016 | SP | New Issue: Bank of Montreal prices $123,000 of 9% cash-settled autocallables on biotech ETF
|
4/29/2016 | SP | New Issue: Bank of Montreal prices $25,000 of 7.2% cash-settled autocallables on biotech ETF
|
4/12/2016 | SP | New Issue: Credit Suisse prices $1.64 million 7.3% airbag autocallables linked to biotech ETF
|
4/12/2016 | SP | New Issue: UBS prices $1.93 million airbag yield optimization autocallables on biotech ETF
|
4/5/2016 | SP | New Issue: UBS prices $132,700 contingent absolute return autocallables on biotech ETF
|
4/5/2016 | SP | BMO plans 9% autocallable cash-settled notes tied to biotech fund
|
4/5/2016 | SP | BMO plans 7.2% autocallable cash-settled notes tied to biotech fund
|
4/1/2016 | SP | New Issue: Bank of Montreal prices $92,000 7.2% cash-settled autocallables linked to biotech ETF
|
4/1/2016 | SP | New Issue: Bank of Montreal prices $184,000 9% cash-settled autocallables linked to biotech ETF
|
3/22/2016 | SP | UBS to price 6.75%-8.75% airbag autocallables linked to biotech ETF
|
3/2/2016 | SP | BMO to price 7.2% autocallable cash-settled notes on biotechnology fund
|
3/2/2016 | SP | BMO to price 9% autocallable cash-settled notes on biotechnology fund
|
2/29/2016 | SP | New Issue: Bank of Montreal prices $277,000 of 9% cash-settled autocallables on biotech ETF
|
2/29/2016 | SP | New Issue: Bank of Montreal sells $30,000 of 7.2% cash-settled autocallables on biotech ETF
|
2/3/2016 | SP | Bank of Montreal plans 9% autocallable cash-settled notes on iShares Nasdaq Biotechnology
|
2/3/2016 | SP | Bank of Montreal plans 7.2% autocallable cash-settled notes on iShares Nasdaq Biotechnology
|
1/28/2016 | SP | New Issue: Bank of Montreal prices $47,000 7.2% cash-settled autocallables on biotech ETF
|
1/28/2016 | SP | New Issue: Bank of Montreal prices $286,000 9% cash-settled autocallables on biotech ETF
|
1/12/2016 | SP | New Issue: UBS prices $25.11 million trigger phoenix autocallables on biotech ETF
|
1/8/2016 | SP | Bank of Montreal plans 9% autocallable cash-settled notes on iShares Nasdaq Biotechnology
|
1/8/2016 | SP | Bank of Montreal plans 7.2% autocallable cash-settled notes on iShares Nasdaq Biotechnology
|
1/5/2016 | SP | UBS plans trigger phoenix autocallables linked to biotechnology ETF
|
1/4/2016 | SP | New Issue: UBS prices $520,950 contingent absolute return autocallables tied to biotech ETF
|
12/30/2015 | SP | New Issue: Bank of Montreal sells $18,000 autocallables on iShares Nasdaq Biotech
|
12/30/2015 | SP | New Issue: Bank of Montreal sells $383,000 autocallables on iShares Nasdaq Biotech
|
12/24/2015 | SP | Bank of Montreal plans 8.4% cash-settled autocallables on biotech ETF
|
12/24/2015 | SP | Bank of Montreal plans 6.6% cash-settled autocallables on biotech ETF
|
12/18/2015 | SP | New Issue: HSBC prices $2 million contingent income barrier notes linked to iShares Nasdaq Biotech
|
12/15/2015 | SP | HSBC plans contingent income barrier notes on iShares Nasdaq Biotech
|
12/4/2015 | SP | New Issue: Bank of Montreal prices $55,000 9.6% autocallable tied to iShares Nasdaq Biotech ETF
|
12/4/2015 | SP | New Issue: Bank of Montreal prices $317,000 7.8% cash-settled autocallables on iShares biotech ETF
|
12/3/2015 | SP | New Issue: UBS prices $160,000 contingent absolute return autocallables on biotechnology ETF
|
12/2/2015 | SP | Market Commentary: HSBC’s autocallables linked to Nasdaq Biotechnology ETF target more conservative yield-seekers
|
12/1/2015 | SP | HSBC plans autocallable yield notes on iShares Nasdaq Biotech ETF
|
11/30/2015 | SP | New Issue: Bank of Montreal prices $16,000 enhanced return notes linked to biotech ETF
|
11/30/2015 | SP | New Issue: Bank of Montreal prices $13,000 enhanced return notes linked to biotech ETF
|
11/11/2015 | SP | New Issue: UBS prices $1.21 million trigger phoenix autocallables linked to iShares Nasdaq Biotechnology
|
11/10/2015 | SP | New Issue: Citigroup prices $2.11 million buffer securities linked to biotech ETF
|
11/10/2015 | SP | Bank of Montreal plans 0.8% autocallables on iShares Nasdaq Biotech
|
11/10/2015 | SP | Bank of Montreal plans 0.6% autocallables on iShares Nasdaq Biotech
|
11/6/2015 | SP | Bank of Montreal plans 7.8% autocallables linked to biotechnology ETF
|
11/6/2015 | SP | Bank of Montreal to price buffered bullish notes on Nasdaq Biotech fund
|
11/6/2015 | SP | Bank of Montreal plans buffered bullish notes on Nasdaq Biotech fund
|
11/5/2015 | SP | UBS to price trigger phoenix autocallables linked to biotech fund
|
11/5/2015 | SP | New Issue: Barclays prices $3.07 million contingent income autocallables on iShares Nasdaq Biotech
|
11/2/2015 | SP | New Issue: Bank of Montreal prices $227,000 9% cash-settled autocallables on biotech ETF
|
11/2/2015 | SP | New Issue: Bank of Montreal prices $30,000 7.2% cash-settled autocallables on biotech ETF
|
11/2/2015 | SP | New Issue: Bank of Montreal prices $100,000 buffered bullish notes on biotech ETF
|
10/29/2015 | SP | New Issue: Bank of Montreal prices $9,000 buffered bullish notes on iShares Nasdaq Biotechnology
|
10/23/2015 | SP | Citigroup plans buffer securities on iShares Nasdaq Biotechnology ETF
|
10/22/2015 | SP | Barclays plans contingent income autocallables on biotechnology ETF
|
10/8/2015 | SP | Market Commentary: Morgan Stanley prices $10.56 million biotech ETF notes; Citigroup readies basket-linked notes
|
10/8/2015 | SP | New Issue: Morgan Stanley prices $10.56 million trigger phoenix autocallables linked to biotech ETF
|
10/5/2015 | SP | Bank of Montreal plans 9% autocallables linked to Nasdaq Biotech ETF
|
10/5/2015 | SP | Bank of Montreal plans 7.2% autocallables tied to Nasdaq Biotech ETF
|
10/5/2015 | SP | Bank of Montreal plans buffered bullish notes due 2017 on biotech ETF
|
10/5/2015 | SP | Bank of Montreal plans buffered bullish two-year notes on biotech ETF
|
10/1/2015 | SP | Morgan Stanley to price trigger phoenix autocallables on biotech ETF
|
10/1/2015 | SP | New Issue: Bank of Montreal prices $48,000 buffered bullish notes on iShares Nasdaq Biotech
|
10/1/2015 | SP | New Issue: Bank of Montreal prices $61,000 buffered bullish notes on iShares Nasdaq Biotech
|
9/30/2015 | SP | New Issue: Bank of Montreal prices $20,000 7.8% autocallables linked to biotech ETF
|
9/30/2015 | SP | New Issue: Bank of Montreal prices $396,000 10.2% autocallables linked to biotech ETF
|
9/4/2015 | SP | Bank of Montreal plans 10.2% cash-settled autocallables on Biotech ETF
|
9/4/2015 | SP | Bank of Montreal plans 7.8% cash-settled autocallables on Biotech ETF
|
9/4/2015 | SP | Bank of Montreal plans buffered bullish two-year notes on biotech ETF
|
9/4/2015 | SP | Bank of Montreal plans buffered bullish notes due 2017 on biotech ETF
|
9/2/2015 | SP | New Issue: Bank of Montreal prices $15,000 enhanced return notes linked to biotech ETF
|
8/7/2015 | SP | Bank of Montreal plans buffered bullish notes linked to biotech fund
|
5/28/2015 | SP | New Issue: Credit Suisse prices $2.38 million autocallable securities on S&P 500, biotech ETF
|
5/26/2015 | SP | New Issue: UBS prices $160,950 return optimization securities linked to biotech ETF
|
5/19/2015 | SP | Credit Suisse plans autocallable securities tied to index, biotech ETF
|
1/21/2015 | SP | New Issue: UBS prices $2.23 million trigger autocallables on iShares Nasdaq Biotechnology ETF
|
12/31/2014 | SP | New Issue: HSBC prices $1 million autocallable plus notes on Russell 2000, iShares biotech fund
|
12/24/2014 | SP | HSBC plans autocallable plus notes on Russell 2000, biotech fund
|
8/1/2014 | SP | New Issue: UBS prices $4.97 million trigger autocallables tied to iShares Nasdaq Biotechnology
|
5/22/2014 | SP | New Issue: JPMorgan prices $902,000 6% autocallable yield notes on fund, index
|
5/20/2014 | SP | New Issue: UBS prices $7.07 million trigger phoenix autocallables linked to biotech ETF
|
5/14/2014 | SP | New Issue: JPMorgan prices $2.9 million autocallable contingent interest notes on biotech fund
|
5/13/2014 | SP | JPMorgan plans autocallable yield notes on Russell, Nasdaq biotech ETF
|
5/13/2014 | SP | Market Commentary: UBS' trigger phoenix autocallables linked to biotech ETF offer high yield but equity-like risk
|
5/12/2014 | SP | UBS plans trigger phoenix autocallables tied to biotechnology ETF
|
5/5/2014 | SP | JPMorgan plans contingent interest autocallables linked to iShares Nasdaq Biotechnology
|
4/30/2014 | SP | New Issue: RBC prices $16.82 million trigger autocallable securities tied to iShares Nasdaq Biotech
|
4/17/2014 | SP | RBC plans trigger autocallables tied to iShares Nasdaq Biotechnology
|
4/4/2014 | SP | Morgan Stanley plans dual directional trigger PLUS on biotech fund
|